< Back to latest news & events

Event

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan

December 2023

Event date: 29th November 2023

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan”

The EPC does not allow ‘medical use’ claims for medial devices. So how do you claim such devices and extend the lifespan of these patents not only in Europe but also in Japan?  Bioinformatic methods of analyses can be filed to accompany such patents but how do the different patent offices treat such claims?

In this webinar we shall provide overview of the law and practice in Europe and Japan, review the landscape of who is filing, what and where, examine relevant case law, and look at some practical examples to help gain a better understanding of what is likely patentable and help determine how to draft within the lines.

Click the button below to watch the full webinar.

Speakers 

Dr Jennifer Uno, HGF

Dr Lauris Kemp, HGF

Dr Masato Iida, Shiga

Kenji Tanaka, Shiga 

Latest updates

Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second installment …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details